Abstracts

Presented to the International Anesthesia Research Society (IARS) 2015:
Werneid K, Riazi S, Brandom BW: Long-term sequelae in patients who experienced a malignant hyperthermia event.
Presented to the American Society of Anesthesiologists (ASA) 2013:
Larach MG, Brandom BW, Allen GC, Gronert GA: Failure to rescue from fulminant malignant hyperthermia: deaths and their genetic variants 2007-2012.
Presented to the American Society of Anesthesiologists (ASA) 2011:
Brandom BW, Wilde J, Young MC: Chronic pain symptoms in malignant hyperthermia.
Presented to the European Malignant Hyperthermia Group 2010:
Brandom BW, Muldoon, SM, Sambuughin N: More than Anesthetic Induced Malignant Hyperthermia (MH).
Presented to the European Malignant Hyperthermia Group 2009:
Brandom BW, Muldoon SM, Wong C, Rosenberg H, Tautz T, Sambuughin N: An Update on the Ryanodine Receptor Gene Variants found in the USA.
Presented to the American Society of Anesthesiologists (ASA) 2008:
Larach MG, Allen GC, Brandom BW, Gronert GA, Lehman EB: Temperature changes are not late signs of malignant hyperthermia: A NAMH Registry of MHAUS Study
Presented to the American Society of Anesthesiologists (ASA) 2008:
Scientific Papers, in review. Larach MG, Allen GC, Brandom BW, Gronert GA, Lehman EB: Serious complications associated with malignant hyperthermia events: A NAMH Registry of MHAUS Study.
Presented to the American Society of Anesthesiologists (ASA) 2007:
Sambuughin N, Brandom B, Capacchione J, Rosenberg H, Muldoon S: Toward updating the North American Malignant Hyperthermia Mutation Panel.
Presented to the American Society of Anesthesiologists (ASA) 2006:
Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB: Deaths associated with malignant hyperthermia (1987-2006). A North American MH Registry of MHAUS Study.
Presented to the American Society of Anesthesiologists (ASA) 2005:
Torp KD, Brandom BW, Capacchione JF, Voelkel ML, Muldoon SM: Caffeine halothane contracture test and ryanodine receptor type 1 analysis in patients who experienced MH episodes.
Presented to the American Society of Anesthesiologists (ASA) in 2005:
Burkman JM, Posner KL, Domino KB: Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions.
Presented to the American Society of Anesthesiologists (ASA) in 2004:
Sambuughin N, Holley H, Brandom B, Nelson T, Muldoon S: Comprehensive screening of the RYR1 gene for malignant hyperthermia susceptibility.
Presented to the European Congress of Nursing in 2004,
previously presented to the American Association of Nurse Anesthethists 2003:
Ciceron MC, Lauriello R, McCarthy EJ, McDonough JP: Differences in clinical manifestations in malignant hyperthermia episodes with succinylcholine or volatile anesthetics.
Presented to the Society for Pediatric Anesthesia 2003:
Brandom BW, Larach MG, Gurgis F: Comparison of pediatric and adult patients with regard to the safety and efficacy of dantrolene.
Presented to the American Society of Anesthesiologists 2002:
Kozack JK: A survey of chronic muscle pain and other symptoms in malignant hyperthermia susceptible individuals.
Presented to the American Society of Anesthesiologists 2002:
Brandom BW, Larach MG: Reassessment of the safety and efficacy of dantrolene.

see also